Sotera Health Announces Fourth-Quarter and Full-Year 2025 Earnings Release Date

Rhea-AI Summary

Sotera Health (Nasdaq: SHC) will release fourth-quarter and full-year 2025 financial results before market open on Tuesday, February 24, 2026. Management will host a conference call at 9:00 a.m. Eastern Time the same day and provide a live webcast and replay via the company Investor Relations site.

Presentation materials and periodic updates, including information related to Ethylene Oxide, will be posted on the Sotera Health Investor Relations web pages.

News Market Reaction – SHC

-0.18%

1 alert

-0.18% News Effect

On the day this news was published, SHC declined 0.18%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings release date: February 24, 2026 Fiscal year-end: December 31, 2025 Conference call time: 9:00 a.m. ET +1 more

4 metrics

Earnings release date February 24, 2026 Q4 and full-year 2025 results to be released before market open

Fiscal year-end December 31, 2025 Fourth-quarter and full-year 2025 reporting period

Conference call time 9:00 a.m. ET Management call to discuss Q4 and full-year 2025 results on release day

Current share price $17.12 Price prior to the earnings date announcement

Market Reality Check

Price: $16.72 Vol: Volume 1,580,176 is at 1....

normal vol

$16.72 Last Close

Volume Volume 1,580,176 is at 1.05x the 20-day average of 1,500,184. normal

Technical Price $17.12 trades above 200-day MA of $15.09 and 13.75% below the 52-week high of $19.85.

Peers on Argus

SHC is up 0.88% with modestly elevated volume. Key peers show mixed moves: RDNT ...

1 Down

SHC is up 0.88% with modestly elevated volume. Key peers show mixed moves: RDNT up 6.51%, GH up 1.9%, while RVTY is down 0.31% and scanner peer QGEN is down 3.69%, indicating stock-specific dynamics rather than a unified sector move.

Common Catalyst Both SHC and peer RDNT issued earnings date/conference call announcements, suggesting a calendar-driven wave of forthcoming results in the diagnostics and health services space.

Historical Context

5 past events · Latest: Feb 05 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 05	Board appointment	Positive	-2.5%	Expanded board and added experienced independent director Richard G. Kyle.
Jan 12	Conference update	Positive	-1.1%	Outlined expected 2025 revenue above <b>$1.16B</b> and multi‑year growth streak.
Jan 07	Conference participation	Neutral	+0.4%	Announced J.P. Morgan conference presentation and availability of webcast materials.
Nov 06	Secondary offering	Negative	-2.1%	Sponsors sold <b>30,000,000</b> shares in a secondary offering; company received no proceeds.
Nov 04	Earnings results	Positive	-1.1%	Reported strong Q3 2025 revenues, earnings, and raised Adjusted EBITDA growth outlook.

Pattern Detected

Recent positive business updates and governance changes often saw negative short-term price reactions, while share overhang events like sponsor secondary offerings aligned with price declines.

Recent Company History

Over the past several months, Sotera Health highlighted revenue growth and balance sheet details while undergoing ownership changes. In Q3 2025, it reported net revenues of $311M and year-to-date revenues of $860M, raising its 2025 Adjusted EBITDA growth outlook and reaffirming revenue growth guidance. Subsequent sponsor secondary offerings in November–December 2025 shifted large share blocks without proceeds to the company. Governance evolved with board expansion and the appointment of Richard G. Kyle on Feb 4, 2026. Today’s earnings date notice fits into this ongoing communication cadence toward the full-year 2025 results.

Market Pulse Summary

This announcement sets the timetable for Sotera Health’s fourth-quarter and full-year 2025 results, ...

Analysis

This announcement sets the timetable for Sotera Health’s fourth-quarter and full-year 2025 results, with a release on February 24, 2026 and a 9:00 a.m. ET conference call. In recent months the company reported growing revenues, updated guidance, and experienced sizeable sponsor sell-downs and new board appointments. Investors may focus on how the upcoming report compares with earlier preliminary revenue indications and prior guidance, as well as any updates on leverage, capital allocation, and ethylene oxide-related developments.

Key Terms

webcast, investor relations, ethylene oxide

3 terms

webcast technical

"A live webcast of the conference call and accompanying materials can be accessed..."

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

investor relations financial

"...via the Investor Relations section of the Company’s website..."

Investor relations is the communication process between a company and its current or potential investors. It involves sharing information about the company's performance, strategies, and outlook to help investors make informed decisions. Effective investor relations build trust and transparency, similar to a clear conversation between a business and someone considering investing, ensuring both parties understand each other's interests and expectations.

ethylene oxide medical

"For developments related to Ethylene Oxide, updates can be found at..."

Ethylene oxide is a flammable, colorless gas used industrially to make plastics and other chemicals and as a sterilizing agent for medical equipment. Investors should care because its use and emissions are tightly regulated—like a tool that can both build products and create legal or cleanup costs—so changes in safety findings, permits, or supply disruptions can affect manufacturing, liabilities, and company valuations.

AI-generated analysis. Not financial advice.

CLEVELAND, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2025 before the market opens on Tuesday, February 24, 2026. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.

A live webcast of the conference call and accompanying materials can be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay of the webcast will be available later in the day on February 24.

Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.

About Sotera Health

Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics^®, Nordion^® and Nelson Labs^®. Sotera Health is committed to its mission, Safeguarding Global Health^®.

INVESTOR RELATIONS CONTACTS:
Jason Peterson
Vice President, Investor Relations
IR@soterahealth.com

MEDIA CONTACT:
Kristin Gibbs
Chief Marketing Officer
kgibbs@soterahealth.com

FAQ

When will Sotera Health (SHC) release Q4 and full-year 2025 earnings?

Sotera Health will release Q4 and full-year 2025 results before market open on February 24, 2026. According to the company, the release covers the quarter and full year ended December 31, 2025 and precedes a management conference call at 9:00 a.m. ET.

What time is Sotera Health's (SHC) earnings conference call on February 24, 2026?

The earnings conference call is scheduled for 9:00 a.m. Eastern Time on February 24, 2026. According to the company, management will discuss operating highlights and financial results and make presentation materials available on the Investor Relations site.

How can investors access the Sotera Health (SHC) webcast and replay for the February 24 call?

Investors can access a live webcast and later replay via the Sotera Health Investor Relations website. According to the company, presentation materials and a replay will be posted the same day on the Presentation & Events and Investor Relations pages.

What period do Sotera Health's (SHC) February 24, 2026 results cover?

The results cover the quarter and full year ended December 31, 2025. According to the company, the announcement and accompanying call will review operating highlights and the financial results for that period.

Will Sotera Health (SHC) provide updates about Ethylene Oxide related matters for investors?

Yes, Sotera Health will post developments related to Ethylene Oxide on its Investor Relations pages. According to the company, updates specific to Ethylene Oxide are available at the dedicated Ethylene Oxide page linked from Investor Relations.